Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:01 am Sale |
2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 1,026,324 2.200% |
-1,156,840 (-52.99%) |
Filing History |
| 2024-11-14 09:00 am Sale |
2024-09-30 | 13G | HilleVax, Inc. HLVX |
Flynn James E | 1,882,654 3.780% |
-2,121,577 (-52.98%) |
Filing History |
| 2024-11-14 08:59 am Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 1,781,006 1.900% |
-2,697,586 (-60.23%) |
Filing History |
| 2024-11-14 08:57 am Purchase |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
Flynn James E | 6,715,501 9.500% |
3,173,501 (+89.60%) |
Filing History |
| 2024-11-14 08:56 am Sale |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
Flynn James E | 0 0.000% |
-2,260,398 (Position Closed) |
Filing History |
| 2024-11-14 08:55 am Sale |
2024-09-30 | 13G | Nkarta, Inc. NKTX |
Flynn James E | 2,155,000 3.050% |
-1,245,000 (-36.62%) |
Filing History |
| 2024-11-14 08:54 am Purchase |
2024-09-30 | 13G | Merus N.V. MRUS |
Flynn James E | 3,408,539 4.980% |
388,638 (+12.87%) |
Filing History |
| 2024-11-14 08:54 am Purchase |
2024-09-30 | 13G | MALLINCKRODT PLC SHS MNKTQ |
Flynn James E | 1,460,233 7.410% |
179,000 (+13.97%) |
Filing History |
| 2024-11-14 08:53 am Unchanged |
2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT |
Flynn James E | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-12 6:58 pm Purchase |
2024-11-06 | 13G | Oscar Health, Inc. OSCR |
Flynn James E | 11,835,000 5.590% |
588,180 (+5.23%) |
Filing History |
| 2024-11-08 4:49 pm Purchase |
2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | Flynn James E | 2,692,625 9.900% |
2,692,625 (New Position) |
Filing History |
| 2024-11-01 7:54 pm Unchanged |
2024-10-31 | 13D | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 249,495 6.660% |
0 (Unchanged) |
Filing History |
| 2024-10-25 5:45 pm Purchase |
2024-10-18 | 13G | Embecta Corp. EMBC |
Flynn James E | 3,075,335 5.330% |
3,075,335 (New Position) |
Filing History |
| 2024-09-20 6:00 pm Purchase |
2024-09-13 | 13G | Foghorn Therapeutics Inc. FHTX |
Flynn James E | 2,935,295 5.310% |
2,935,295 (New Position) |
Filing History |
| 2024-09-12 4:07 pm Purchase |
2024-09-05 | 13D | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 249,495 6.660% |
249,495 (New Position) |
Filing History |
| 2024-07-11 6:47 pm Purchase |
2024-07-09 | 13D | BiomX Inc. PHGE |
Flynn James E | 15,558,445 9.990% |
14,947,435 (+2446.35%) |
Filing History |
| 2024-05-30 7:26 pm Unchanged |
2024-05-30 | 13D | BiomX Inc. PHGE |
Flynn James E | 611,010 8.750% |
0 (Unchanged) |
Filing History |
| 2024-05-17 5:14 pm Purchase |
2024-05-07 | 13G | Alignment Healthcare, Inc. ALHC |
Flynn James E | 10,865,513 5.680% |
10,865,513 (New Position) |
Filing History |
| 2024-05-15 6:39 pm Purchase |
2024-05-15 | 13G | Nuvalent, Inc. NUVL |
Flynn James E | 25,579,890 33.990% |
102,114 (+0.40%) |
Filing History |
| 2024-04-24 5:50 pm Purchase |
2024-04-18 | 13G | Cullinan Oncology, Inc. CGEM |
Flynn James E | 3,283,824 5.710% |
3,283,824 (New Position) |
Filing History |